検索
Pharming Group NV
PHARウォッチリストに追加
10.440USD
-0.330-3.06%
終値 09-24 16:00（ET）
738.92M時価総額
0.00直近12ヶ月PER
Pharming Group NVについて 企業名
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Pharming Group NV プロフィール
企業コードPHAR
会社名Pharming Group NV
上場日Jul 02, 1998
最高経営責任者「CEO」Chouraqui (Fabrice)
従業員数- -
証券種類Depository Receipt
決算期末- -
本社所在地Darwinweg 24
都市LEIDEN
証券取引所NASDAQ OMX - NASDAQ BASIC
国Netherlands
郵便番号2333 CR
電話番号31715247400
ウェブサイトhttps://www.pharming.com/
企業コードPHAR
上場日Jul 02, 1998
最高経営責任者「CEO」Chouraqui (Fabrice)
Pharming Group NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni, J.D.
Ms. Barbara Yanni, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jabine van Der Meijs, Pharm.D.
Ms. Jabine van Der Meijs, Pharm.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ruud van Outersterp
Mr. Ruud van Outersterp
Chief Legal and Compliance Officer, Company Secretary
Chief Legal and Compliance Officer, Company Secretary
--
--
Dr. Richard Peters, M.D., Ph.D.
Dr. Richard Peters, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Alexander Breidenbach, Ph.D.
Dr. Alexander Breidenbach, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Mr. Fabrice Chouraqui, Pharm.D.
Mr. Fabrice Chouraqui, Pharm.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni, J.D.
Ms. Barbara Yanni, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jabine van Der Meijs, Pharm.D.
Ms. Jabine van Der Meijs, Pharm.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
よくある質問
Pharming Group NVの上位5名の株主は誰ですか？
Pharming Group NVの上位5名の株主は以下のとおりです。Mrs. Mireille Sanders
Pharming Group NV（PHAR）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Pharming Group NVの株式を保有している機関は22社あり、保有株式の総市場価値は約135.73Kで、全体の0.19%を占めています。2025Q4と比較して、機関の持ち株は61813.00増加しています。